首页 > 最新文献

Antimicrobial Resistance and Infection Control最新文献

英文 中文
WHO/INRUD prescribing indicators with a focus on antibiotics utilization patterns at outpatient department of Adigrat general hospital, Tigrai, Ethiopia: a retrospective cross-sectional study. 埃塞俄比亚提格雷省阿迪格拉特综合医院门诊部抗生素使用模式的世卫组织/INRUD处方指标:一项回顾性横断面研究。
IF 4.8 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-11-06 DOI: 10.1186/s13756-024-01490-6
Gebretekle Gebremichael Hailesilase, Brhane Gebrehiwot Welegebrial, Mezgebe Gidey Weres, Senait Abera Gebrewahd

Background: The World Health Organization (WHO) defines rational use of drug as a state in which medications are received by patients appropriately according to their clinical needs and individual requirement, for adequate period and at the right cost. More than 50% of all medicines are prescribed, dispensed, or sold inappropriately worldwide. This study aimed to evaluate the prescribing patterns in Adigrat general hospital, Tigrai, Ethiopia.

Methods: A retrospective cross-sectional study was done to evaluate prescription patterns. A systematic random sampling technique was used to select 600 prescriptions and the prescriptions were reviewed using WHO/International Network of Rational Use of Drugs prescribing indicators. Data was collected from prescriptions dispensed from 01 March 2023 to 30 March 2024 at outpatient pharmacy of Adigrat general hospital. Data was analyzed using SPSS version 21 and a p-value < 0.05 was declared statistically significant.

Results: A total of 1088 medicines were prescribed in 600 prescription encounters, giving an average number of 1.8 (± 0.83) medicines per encounter. The percentage of medicines prescribed by generic name was 91.5% while 98.7% of the medicines were prescribed from essential medicine list (EML). Besides, the percentages of encounters containing at least one antibiotic and one injection were 44.5% and 7.2%, respectively. A total of 340 antibiotics were prescribed in 267 encounters. Penicillins (34.4%), macrolides (23.8%) and fluoroquinolones (17.1%) were the most prevalent antibiotics classes. The "Access" and "Watch" groups covered 54.4% and 45.6% of the total antibiotics prescribed, respectively. Being under 18 years old [Adjusted Odds Ratio (AOR): 9.830, CI: 4.062-23.786], being prescribed with three medicines (AOR: 3.247, CI: 1.571-6.708) and certain diagnosis like diseases of the respiratory system (AOR: 3.750, CI: 2.136-6.584) were significantly associated with antibiotic prescribing.

Conclusion: This study showed deviations of prescribing patterns from WHO standards. The percentage of prescriptions with antibiotic was far from WHO optimal value. The use of antibiotics from "Access" group was below WHO standard. The percentage of medicines prescribed by generic name and the percentage of encounters with injection also deviated from WHO standard. Antibiotics prescribing showed significantly association with age, number of medicines and certain diseases.

背景:世界卫生组织(WHO)对合理用药的定义是:患者根据自己的临床需要和个人要求,在适当的时间内,以适当的价格获得适当的药物。在全球范围内,50% 以上的药物被不当处方、配发或销售。本研究旨在评估埃塞俄比亚提格雷省阿迪格拉特综合医院的处方模式:方法:采用回顾性横断面研究来评估处方模式。采用系统随机抽样技术抽取了 600 份处方,并使用世界卫生组织/国际合理用药网络的处方指标对处方进行了审查。数据收集自 2023 年 3 月 1 日至 2024 年 3 月 30 日在阿迪格拉特综合医院门诊药房开具的处方。数据分析采用 SPSS 21 版和 P 值:600 次处方共开出 1088 种药品,平均每次开出 1.8 (± 0.83) 种药品。按通用名处方的药品占 91.5%,而 98.7%的药品来自基本药物目录(EML)。此外,至少含有一种抗生素和一种注射剂的病例比例分别为 44.5%和 7.2%。在 267 次就诊中,共开出了 340 种抗生素处方。青霉素类(34.4%)、大环内酯类(23.8%)和氟喹诺酮类(17.1%)是最常用的抗生素类别。使用 "组和 "观察 "组分别占抗生素处方总量的 54.4% 和 45.6%。18 岁以下[调整比值比(AOR):9.830,CI:4.062-23.786]、处方三种药物(AOR:3.247,CI:1.571-6.708)和某些诊断(如呼吸系统疾病)(AOR:3.750,CI:2.136-6.584)与抗生素处方显著相关:本研究表明,处方模式与世界卫生组织的标准存在偏差。使用抗生素的处方比例与世界卫生组织的最佳值相去甚远。无障碍 "组抗生素的使用低于世卫组织标准。使用通用名开具处方的比例和使用注射剂开具处方的比例也偏离了世界卫生组织的标准。抗生素处方与年龄、用药次数和某些疾病有明显关联。
{"title":"WHO/INRUD prescribing indicators with a focus on antibiotics utilization patterns at outpatient department of Adigrat general hospital, Tigrai, Ethiopia: a retrospective cross-sectional study.","authors":"Gebretekle Gebremichael Hailesilase, Brhane Gebrehiwot Welegebrial, Mezgebe Gidey Weres, Senait Abera Gebrewahd","doi":"10.1186/s13756-024-01490-6","DOIUrl":"10.1186/s13756-024-01490-6","url":null,"abstract":"<p><strong>Background: </strong>The World Health Organization (WHO) defines rational use of drug as a state in which medications are received by patients appropriately according to their clinical needs and individual requirement, for adequate period and at the right cost. More than 50% of all medicines are prescribed, dispensed, or sold inappropriately worldwide. This study aimed to evaluate the prescribing patterns in Adigrat general hospital, Tigrai, Ethiopia.</p><p><strong>Methods: </strong>A retrospective cross-sectional study was done to evaluate prescription patterns. A systematic random sampling technique was used to select 600 prescriptions and the prescriptions were reviewed using WHO/International Network of Rational Use of Drugs prescribing indicators. Data was collected from prescriptions dispensed from 01 March 2023 to 30 March 2024 at outpatient pharmacy of Adigrat general hospital. Data was analyzed using SPSS version 21 and a p-value < 0.05 was declared statistically significant.</p><p><strong>Results: </strong>A total of 1088 medicines were prescribed in 600 prescription encounters, giving an average number of 1.8 (± 0.83) medicines per encounter. The percentage of medicines prescribed by generic name was 91.5% while 98.7% of the medicines were prescribed from essential medicine list (EML). Besides, the percentages of encounters containing at least one antibiotic and one injection were 44.5% and 7.2%, respectively. A total of 340 antibiotics were prescribed in 267 encounters. Penicillins (34.4%), macrolides (23.8%) and fluoroquinolones (17.1%) were the most prevalent antibiotics classes. The \"Access\" and \"Watch\" groups covered 54.4% and 45.6% of the total antibiotics prescribed, respectively. Being under 18 years old [Adjusted Odds Ratio (AOR): 9.830, CI: 4.062-23.786], being prescribed with three medicines (AOR: 3.247, CI: 1.571-6.708) and certain diagnosis like diseases of the respiratory system (AOR: 3.750, CI: 2.136-6.584) were significantly associated with antibiotic prescribing.</p><p><strong>Conclusion: </strong>This study showed deviations of prescribing patterns from WHO standards. The percentage of prescriptions with antibiotic was far from WHO optimal value. The use of antibiotics from \"Access\" group was below WHO standard. The percentage of medicines prescribed by generic name and the percentage of encounters with injection also deviated from WHO standard. Antibiotics prescribing showed significantly association with age, number of medicines and certain diseases.</p>","PeriodicalId":7950,"journal":{"name":"Antimicrobial Resistance and Infection Control","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11539567/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contextual barriers to infection prevention and control program implementation in hospitals in Latin America: a mixed methods evaluation. 拉丁美洲医院实施感染预防与控制计划的环境障碍:混合方法评估。
IF 4.8 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-11-03 DOI: 10.1186/s13756-024-01484-4
Valeria Fabre, Clara Secaira, Carolyn Herzig, Elizabeth Bancroft, Maria Paula Bernachea, Lucy Anchiraico Galarza, Bowen Aquiles, Ana Belén Arauz, Maria Del Carmen Bangher, Marisa Liliana Bernan, Sol Burokas, Alfredo Canton, Iris L Cazali, Angel Colque, Marisabel Comas, Rosa Verónica Contreras, Wanda Cornistein, Maria Gabriela Cordoba, Silvia Mabel Correa, Gustavo Costilla Campero, Marta Isabel Chamorro Ayala, Nuria Chavez, Gabriela De Ascencao, Carlos Cruz García, Clara Esquivel, Cecilia Ezcurra, Leonardo Fabbro, Leandro Falleroni, Johana Fernandez, Sandra Ferrari, Veronica Freire, Maria Isabel Garzón, José Anel Gonzales, Lucrecia Guaymas, Fausto Guerrero-Toapanta, Diego Laplume, Sandra Lambert, César Guillermo Lemir, Paola Romina Lazarte, Itzel L Lopez, Herberth Maldonado, Guadalupe Martínez, Diego M Maurizi, Florencia Mesplet, Cristina Moreno Izquierdo, Gabriela Luciana Moya, Mariela Nájera, Yanina Nuccetelli, Argelis Olmedo, Belén Palacio, Florencia Pellice, Carla Lorena Raffo, Carolina Ramos, Fanny Reino, Viviana Rodriguez, Federico Romero, Juan José Romero, Graciela Sadino, Nancy Sandoval, Mariana Suarez, Maria Victoria Suayter, Maria Alejandra Ureña, Marisol Valle, Ligia Vence Reyes, Silvia Vera Amate Perez, Hugo Videla, Silvina Villamandos, Olmedo Villarreal, Maria Alejandra Viteri, Eduardo Warley, Rodolfo E Quiros

Background: Infection prevention and control (IPC) programs are essential to prevent and control the spread of multidrug-resistant organisms in healthcare facilities (HCFs). The current implementation of these programs in Latin America remains largely unknown.

Methods: We conducted a mixed-methods evaluation of IPC program implementation in HCFs from Guatemala, Panama, Ecuador, and Argentina, March-July 2022. We used the World Health Organization (WHO) IPC Assessment Framework (IPCAF) survey, a previously validated structured questionnaire with an associated scoring system that evaluates the eight core components of IPC (IPC program; IPC guidelines; IPC education and training; healthcare-associated infection [HAI] surveillance; multimodal strategies; monitoring and audit of IPC practices and feedback; workload, staffing, and bed occupancy; and the built environment and materials and equipment for IPC). Each section generates a score 0-100. According to the final score, the HCF IPC program implementation is categorized into four levels: inadequate (0-200), basic (201-400), intermediate (401-600), or advanced (601-800). Additionally, we conducted semi-structured interviews among IPC personnel and microbiologists using the Systems Engineering Initiative for Patient Safety model to evaluate barriers and facilitators for IPC program implementation. We performed directed content analysis of interview transcripts to identify themes that focused on barriers and facilitators of IPC program implementation which are summarized descriptively.

Results: Thirty-seven HCFs (15 for-profit and 22 non-profit) completed the IPCAF survey. The overall median score was 614 (IQR 569, 693) which corresponded to an "advanced" level of IPC implementation (32% [7/22] non-profit vs. 93% [14/15] for-profit HCFs in this category). The lowest scores were in workload, staffing and bed occupancy followed by IPC training and multimodal strategies. Forty individuals from 16 HCFs were interviewed. They perceived inadequate staffing and technical resources, limited leadership support, and cultural determinants as major barriers to effective IPC guideline implementation, while external accreditation and technical support from public health authorities were perceived as facilitators.

Conclusions: Efforts to strengthen IPC activities in Latin American HCFs should focus on improving support from hospital leadership and public health authorities to ensure better resource allocation, promoting safety culture, and improving training in quality improvement.

背景:感染预防与控制(IPC)计划对于预防和控制耐多药生物在医疗机构(HCF)中的传播至关重要。这些计划目前在拉丁美洲的实施情况在很大程度上仍不为人所知:我们采用混合方法对 2022 年 3 月至 7 月期间危地马拉、巴拿马、厄瓜多尔和阿根廷的医疗机构实施 IPC 计划的情况进行了评估。我们采用了世界卫生组织(WHO)的IPC评估框架(IPCAF)调查,这是一份事先经过验证的结构化问卷,并配有相关的评分系统,用于评估IPC的八个核心组成部分(IPC计划;IPC指南;IPC教育和培训;医源性感染监测;多模式策略;IPC实践和反馈的监测与审核;工作量、人员配备和床位占用率;以及建筑环境和IPC材料与设备)。每个部分的得分均为 0-100。根据最终得分,HCF IPC 项目实施情况分为四个等级:不足(0-200 分)、基础(201-400 分)、中级(401-600 分)或高级(601-800 分)。此外,我们还采用 "患者安全系统工程倡议 "模型对 IPC 人员和微生物学家进行了半结构化访谈,以评估 IPC 计划实施的障碍和促进因素。我们对访谈记录进行了定向内容分析,以确定有关 IPC 项目实施障碍和促进因素的主题,并对这些主题进行了描述性总结:37 家保健基金会(15 家营利性基金会和 22 家非营利性基金会)完成了 IPCAF 调查。总得分中位数为 614 分(IQR 为 569 分至 693 分),相当于 IPC 实施的 "高级 "水平(32% [7/22] 非营利性医疗机构与 93% [14/15] 营利性医疗机构在此类别中)。得分最低的是工作量、人员配备和病床占用率,其次是 IPC 培训和多模式策略。来自 16 家护理机构的 40 人接受了访谈。他们认为,人员配备和技术资源不足、领导支持有限以及文化决定因素是有效实施IPC指南的主要障碍,而来自公共卫生机构的外部认证和技术支持则是促进因素:结论:在拉丁美洲的医疗保健设施中,加强IPC活动的工作重点应放在改善医院领导层和公共卫生机构的支持上,以确保更好地分配资源、促进安全文化以及改善质量改进方面的培训。
{"title":"Contextual barriers to infection prevention and control program implementation in hospitals in Latin America: a mixed methods evaluation.","authors":"Valeria Fabre, Clara Secaira, Carolyn Herzig, Elizabeth Bancroft, Maria Paula Bernachea, Lucy Anchiraico Galarza, Bowen Aquiles, Ana Belén Arauz, Maria Del Carmen Bangher, Marisa Liliana Bernan, Sol Burokas, Alfredo Canton, Iris L Cazali, Angel Colque, Marisabel Comas, Rosa Verónica Contreras, Wanda Cornistein, Maria Gabriela Cordoba, Silvia Mabel Correa, Gustavo Costilla Campero, Marta Isabel Chamorro Ayala, Nuria Chavez, Gabriela De Ascencao, Carlos Cruz García, Clara Esquivel, Cecilia Ezcurra, Leonardo Fabbro, Leandro Falleroni, Johana Fernandez, Sandra Ferrari, Veronica Freire, Maria Isabel Garzón, José Anel Gonzales, Lucrecia Guaymas, Fausto Guerrero-Toapanta, Diego Laplume, Sandra Lambert, César Guillermo Lemir, Paola Romina Lazarte, Itzel L Lopez, Herberth Maldonado, Guadalupe Martínez, Diego M Maurizi, Florencia Mesplet, Cristina Moreno Izquierdo, Gabriela Luciana Moya, Mariela Nájera, Yanina Nuccetelli, Argelis Olmedo, Belén Palacio, Florencia Pellice, Carla Lorena Raffo, Carolina Ramos, Fanny Reino, Viviana Rodriguez, Federico Romero, Juan José Romero, Graciela Sadino, Nancy Sandoval, Mariana Suarez, Maria Victoria Suayter, Maria Alejandra Ureña, Marisol Valle, Ligia Vence Reyes, Silvia Vera Amate Perez, Hugo Videla, Silvina Villamandos, Olmedo Villarreal, Maria Alejandra Viteri, Eduardo Warley, Rodolfo E Quiros","doi":"10.1186/s13756-024-01484-4","DOIUrl":"10.1186/s13756-024-01484-4","url":null,"abstract":"<p><strong>Background: </strong>Infection prevention and control (IPC) programs are essential to prevent and control the spread of multidrug-resistant organisms in healthcare facilities (HCFs). The current implementation of these programs in Latin America remains largely unknown.</p><p><strong>Methods: </strong>We conducted a mixed-methods evaluation of IPC program implementation in HCFs from Guatemala, Panama, Ecuador, and Argentina, March-July 2022. We used the World Health Organization (WHO) IPC Assessment Framework (IPCAF) survey, a previously validated structured questionnaire with an associated scoring system that evaluates the eight core components of IPC (IPC program; IPC guidelines; IPC education and training; healthcare-associated infection [HAI] surveillance; multimodal strategies; monitoring and audit of IPC practices and feedback; workload, staffing, and bed occupancy; and the built environment and materials and equipment for IPC). Each section generates a score 0-100. According to the final score, the HCF IPC program implementation is categorized into four levels: inadequate (0-200), basic (201-400), intermediate (401-600), or advanced (601-800). Additionally, we conducted semi-structured interviews among IPC personnel and microbiologists using the Systems Engineering Initiative for Patient Safety model to evaluate barriers and facilitators for IPC program implementation. We performed directed content analysis of interview transcripts to identify themes that focused on barriers and facilitators of IPC program implementation which are summarized descriptively.</p><p><strong>Results: </strong>Thirty-seven HCFs (15 for-profit and 22 non-profit) completed the IPCAF survey. The overall median score was 614 (IQR 569, 693) which corresponded to an \"advanced\" level of IPC implementation (32% [7/22] non-profit vs. 93% [14/15] for-profit HCFs in this category). The lowest scores were in workload, staffing and bed occupancy followed by IPC training and multimodal strategies. Forty individuals from 16 HCFs were interviewed. They perceived inadequate staffing and technical resources, limited leadership support, and cultural determinants as major barriers to effective IPC guideline implementation, while external accreditation and technical support from public health authorities were perceived as facilitators.</p><p><strong>Conclusions: </strong>Efforts to strengthen IPC activities in Latin American HCFs should focus on improving support from hospital leadership and public health authorities to ensure better resource allocation, promoting safety culture, and improving training in quality improvement.</p>","PeriodicalId":7950,"journal":{"name":"Antimicrobial Resistance and Infection Control","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11533356/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142567888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical site infection and antimicrobial use following caesarean section at QECH in Blantyre, Malawi: a prospective cohort study. 马拉维布兰太尔 QECH 医院剖腹产手术后的手术部位感染和抗菌药物使用情况:一项前瞻性队列研究。
IF 4.8 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-29 DOI: 10.1186/s13756-024-01483-5
Amos Tumizani Kachipedzu, David King Kulapani, Samuel James Meja, Janelisa Musaya

Background: Surgical site infections (SSIs) are one of the most common healthcare-associated infections and preventable complication of surgical procedure; continue to threaten public health with significant effects on the patients and health care human and financial resources. Therefore, this study aimed to determine the incidence of SSIs, risk factors and common microorganisms associated with SSI and assess the practice of antimicrobial use in women following Caesarean Section (CS) at Queen Elizabeth Central Hospital (QECH).

Methods: This was a hospital-based quantitative prospective study design involving pregnant women who underwent a CS between February, 2023 and July, 2023 at QECH with 30 day-follow-ups. Wound specimens (wound swabs) were collected from all infected CS wounds and processed at QECH main laboratory, and susceptibility testing was conducted using the Kirby-Bauer disk diffusion method with results reported only as susceptible, intermediate, or resistant and the collected data was analyzed using Stata.

Results: The overall cumulative incidence of SSI recorded at QECH during the study period was 9.61% (20 cases out of 208). Of these, 19 (95%) of them reported superficial SSI following CS. The mean age was 26.1 years with a standard deviation of 6.2. All pregnant women who underwent for CS received antibiotic prophylaxis. This study revealed that 138 (66.35%) patients received both preoperative antibiotics (ceftriaxone) and post-CS antibiotics without knowing the specific bacterial organism isolated. This study revealed that ruptured membrane had twice the incidence of SSIs compared to intact membrane (χ2 = 2.0922), though not statistically significant. The majority of patients with SSIs (n = 12, 60%) were readmitted and 5 (25%) out of 20 with SSIs had antimicrobial resistance following susceptibility testing. Staphylococcus aureus was the most common organism (3, 60%) and other bacterial isolates included were Enterobacteriaceae and Acinetobacter baumanni.

Conclusion: The incidence of SSIs and inappropriate antimicrobial use following CS remains a challenge at QECH. Therefore, due to increased number of SSIs following CS with relative emergence of AMR ensure intensive infection prevention and control practices, establishing AMS program and routine surveillance of SSIs at QECH.

背景:手术部位感染(SSI)是最常见的医疗相关感染之一,也是手术过程中可预防的并发症;它继续威胁着公众健康,对患者和医疗保健的人力和财力资源造成重大影响。因此,本研究旨在确定伊丽莎白女王中央医院(QECH)剖腹产(CS)术后妇女的 SSI 发生率、风险因素和与 SSI 相关的常见微生物,并评估抗菌药物的使用情况:这是一项基于医院的定量前瞻性研究,涉及2023年2月至2023年7月期间在伊丽莎白女王中央医院接受剖腹产手术的孕妇,并进行30天随访。从所有感染的CS伤口采集伤口标本(伤口拭子),并在QECH主实验室进行处理,使用Kirby-Bauer盘扩散法进行药敏试验,结果仅报告为易感、中度或耐药,并使用Stata对收集的数据进行分析:研究期间,青海省儿童医院记录的 SSI 总累计发病率为 9.61%(208 例中有 20 例)。其中,19 例(95%)报告了 CS 后的表皮 SSI。平均年龄为 26.1 岁,标准差为 6.2 岁。所有接受 CS 的孕妇都接受了抗生素预防治疗。本研究显示,138 例(66.35%)患者术前服用了头孢曲松(ceftriaxone),术后服用了抗生素,但并不知道分离出的具体细菌是什么。该研究显示,与完整膜相比,破裂膜的 SSI 发生率是完整膜的两倍(χ2 = 2.0922),但无统计学意义。大多数 SSI 患者(12 人,60%)再次入院,20 名 SSI 患者中有 5 人(25%)在药敏试验后对抗菌素产生耐药性。金黄色葡萄球菌是最常见的病原体(3 例,占 60%),其他细菌分离物包括肠杆菌科和鲍曼不动杆菌:结论:在青科医院,CS后SSI的发生率和抗菌药物的不当使用仍是一项挑战。因此,鉴于 CS 后 SSI 的增加以及 AMR 的相对出现,QECH 应加强感染预防和控制措施,制定 AMS 计划并对 SSI 进行常规监测。
{"title":"Surgical site infection and antimicrobial use following caesarean section at QECH in Blantyre, Malawi: a prospective cohort study.","authors":"Amos Tumizani Kachipedzu, David King Kulapani, Samuel James Meja, Janelisa Musaya","doi":"10.1186/s13756-024-01483-5","DOIUrl":"10.1186/s13756-024-01483-5","url":null,"abstract":"<p><strong>Background: </strong>Surgical site infections (SSIs) are one of the most common healthcare-associated infections and preventable complication of surgical procedure; continue to threaten public health with significant effects on the patients and health care human and financial resources. Therefore, this study aimed to determine the incidence of SSIs, risk factors and common microorganisms associated with SSI and assess the practice of antimicrobial use in women following Caesarean Section (CS) at Queen Elizabeth Central Hospital (QECH).</p><p><strong>Methods: </strong>This was a hospital-based quantitative prospective study design involving pregnant women who underwent a CS between February, 2023 and July, 2023 at QECH with 30 day-follow-ups. Wound specimens (wound swabs) were collected from all infected CS wounds and processed at QECH main laboratory, and susceptibility testing was conducted using the Kirby-Bauer disk diffusion method with results reported only as susceptible, intermediate, or resistant and the collected data was analyzed using Stata.</p><p><strong>Results: </strong>The overall cumulative incidence of SSI recorded at QECH during the study period was 9.61% (20 cases out of 208). Of these, 19 (95%) of them reported superficial SSI following CS. The mean age was 26.1 years with a standard deviation of 6.2. All pregnant women who underwent for CS received antibiotic prophylaxis. This study revealed that 138 (66.35%) patients received both preoperative antibiotics (ceftriaxone) and post-CS antibiotics without knowing the specific bacterial organism isolated. This study revealed that ruptured membrane had twice the incidence of SSIs compared to intact membrane (χ<sup>2</sup> = 2.0922), though not statistically significant. The majority of patients with SSIs (n = 12, 60%) were readmitted and 5 (25%) out of 20 with SSIs had antimicrobial resistance following susceptibility testing. Staphylococcus aureus was the most common organism (3, 60%) and other bacterial isolates included were Enterobacteriaceae and Acinetobacter baumanni.</p><p><strong>Conclusion: </strong>The incidence of SSIs and inappropriate antimicrobial use following CS remains a challenge at QECH. Therefore, due to increased number of SSIs following CS with relative emergence of AMR ensure intensive infection prevention and control practices, establishing AMS program and routine surveillance of SSIs at QECH.</p>","PeriodicalId":7950,"journal":{"name":"Antimicrobial Resistance and Infection Control","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11520451/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antimicrobial surface coating in the emergency department as protective technology for infection control (ASEPTIC): a pilot randomized controlled trial. 急诊科抗菌表面涂层作为感染控制保护技术(ASEPTIC):随机对照试验。
IF 4.8 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-29 DOI: 10.1186/s13756-024-01481-7
Lenard Cheng, Shun Yee Low, Yuru Boon, Carmen Goh, Abigail Ng, Alexander Jet Yue Ng, Joshua Teo, Nur Humaira Johari, Yong Hao Pua, Mui Teng Chua, Win Sen Kuan

Study objective: We examined the effectiveness of an antimicrobial surface coating for continual disinfection of high touch-frequency surfaces in the emergency department (ED).

Methods: Following a preliminary observation identifying stretcher rails as the surface with highest touch-frequency in the ED, we conducted a pilot randomized controlled trial involving 96 stretcher rails. The stretchers were randomized to receive an antimicrobial surface coating or placebo coating. Routine cleaning of stretchers subsequently continued as per hospital protocol in both arms. Sampling for total aerobic, gram-positive halophilic, gram-negative and methicillin-resistant Staphylococcus aureus bacteria was performed pre- and post-treatment at 24 h, 7 days and 180 days. Individuals who applied the coating and outcome assessors were blinded to the allocated arms. The primary outcome is contamination of antimicrobial versus placebo rails measured as colony forming units per cm2(CFU/cm2).

Results: Baseline total aerobic bacteria was comparable between placebo and intervention arms (0.84 versus 1.32 CFU/cm2, P = 0.235). Total aerobic bacteria contamination was significantly lower on antimicrobial versus placebo rails at 24 h (0.61 versus 1.01 CFU/cm2, median difference 0.40 CFU/cm2, 95% confidence interval [CI] 0.01 to 1.01 CFU/cm2). There was a non-statistically significant tendency for contamination to be lower on antimicrobial versus placebo rails at 7 days (1.15 versus 1.50 CFU/cm2, median difference 0.35 CFU/cm2, 95% CI -0.64 to 1.28 CFU/cm2), but higher at 180 days (2.06 versus 1.84 CFU/cm2, median difference - 0.22 CFU/cm2, 95% CI -1.19 to 0.78 CFU/cm2).

Conclusion: This is the first double-blinded, placebo-controlled, randomized trial to evaluate an antimicrobial surface coating on high touch-frequency surfaces in the emergency department. Total aerobic bacteria found on antimicrobial-coated patient transport stretcher rails was significantly lower than placebo rails at 24 h.

研究目的我们研究了抗菌表面涂层对急诊科(ED)高接触频率表面进行持续消毒的效果:经过初步观察,我们发现担架栏杆是急诊室中接触频率最高的表面,于是我们对 96 个担架栏杆进行了随机对照试验。担架被随机分配为抗菌表面涂层或安慰剂涂层。随后,两组担架均按照医院规定进行常规清洁。在治疗前和治疗后的 24 小时、7 天和 180 天,分别对总需氧菌、革兰氏阳性嗜卤菌、革兰氏阴性菌和耐甲氧西林金黄色葡萄球菌进行采样。涂抹涂层的人员和结果评估人员对所分配的臂盲。主要结果是以每平方厘米菌落形成单位(CFU/cm2)来衡量抗菌剂与安慰剂的污染情况:结果:安慰剂组和干预组的基线需氧菌总数相当(0.84 对 1.32 CFU/cm2,P = 0.235)。24 小时后,抗菌剂与安慰剂护栏上的需氧菌污染总数明显降低(0.61 CFU/cm2 与 1.01 CFU/cm2,中位数差异为 0.40 CFU/cm2,95% 置信区间 [CI] 为 0.01 至 1.01 CFU/cm2)。在7天时,抗菌剂与安慰剂护栏的污染程度有差异(1.15 CFU/cm2 与 1.50 CFU/cm2,中位差异为 0.35 CFU/cm2,95% CI -0.64 至 1.28 CFU/cm2),但在180天时污染程度较高(2.06 CFU/cm2 与 1.84 CFU/cm2,中位差异为 -0.22 CFU/cm2,95% CI -1.19 至 0.78 CFU/cm2):这是首个评估急诊科高频触摸表面抗菌涂层的双盲、安慰剂对照随机试验。24 小时后,在涂有抗菌剂的病人运送担架栏杆上发现的需氧菌总数明显低于安慰剂栏杆。
{"title":"Antimicrobial surface coating in the emergency department as protective technology for infection control (ASEPTIC): a pilot randomized controlled trial.","authors":"Lenard Cheng, Shun Yee Low, Yuru Boon, Carmen Goh, Abigail Ng, Alexander Jet Yue Ng, Joshua Teo, Nur Humaira Johari, Yong Hao Pua, Mui Teng Chua, Win Sen Kuan","doi":"10.1186/s13756-024-01481-7","DOIUrl":"10.1186/s13756-024-01481-7","url":null,"abstract":"<p><strong>Study objective: </strong>We examined the effectiveness of an antimicrobial surface coating for continual disinfection of high touch-frequency surfaces in the emergency department (ED).</p><p><strong>Methods: </strong>Following a preliminary observation identifying stretcher rails as the surface with highest touch-frequency in the ED, we conducted a pilot randomized controlled trial involving 96 stretcher rails. The stretchers were randomized to receive an antimicrobial surface coating or placebo coating. Routine cleaning of stretchers subsequently continued as per hospital protocol in both arms. Sampling for total aerobic, gram-positive halophilic, gram-negative and methicillin-resistant Staphylococcus aureus bacteria was performed pre- and post-treatment at 24 h, 7 days and 180 days. Individuals who applied the coating and outcome assessors were blinded to the allocated arms. The primary outcome is contamination of antimicrobial versus placebo rails measured as colony forming units per cm<sup>2</sup>(CFU/cm<sup>2</sup>).</p><p><strong>Results: </strong>Baseline total aerobic bacteria was comparable between placebo and intervention arms (0.84 versus 1.32 CFU/cm<sup>2</sup>, P = 0.235). Total aerobic bacteria contamination was significantly lower on antimicrobial versus placebo rails at 24 h (0.61 versus 1.01 CFU/cm<sup>2</sup>, median difference 0.40 CFU/cm<sup>2</sup>, 95% confidence interval [CI] 0.01 to 1.01 CFU/cm<sup>2</sup>). There was a non-statistically significant tendency for contamination to be lower on antimicrobial versus placebo rails at 7 days (1.15 versus 1.50 CFU/cm<sup>2</sup>, median difference 0.35 CFU/cm<sup>2</sup>, 95% CI -0.64 to 1.28 CFU/cm<sup>2</sup>), but higher at 180 days (2.06 versus 1.84 CFU/cm<sup>2</sup>, median difference - 0.22 CFU/cm<sup>2</sup>, 95% CI -1.19 to 0.78 CFU/cm<sup>2</sup>).</p><p><strong>Conclusion: </strong>This is the first double-blinded, placebo-controlled, randomized trial to evaluate an antimicrobial surface coating on high touch-frequency surfaces in the emergency department. Total aerobic bacteria found on antimicrobial-coated patient transport stretcher rails was significantly lower than placebo rails at 24 h.</p>","PeriodicalId":7950,"journal":{"name":"Antimicrobial Resistance and Infection Control","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11520898/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142520775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful control of an environmental reservoir of NDM-producing Klebsiella pneumoniae associated with nosocomial transmissions in a low-incidence setting. 在一个低发病率环境中,成功控制了一个与医院内传播有关的产NDM肺炎克雷伯氏菌环境库。
IF 4.8 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-29 DOI: 10.1186/s13756-024-01488-0
Estelle Moulin, Paraskevas Filippidis, Corinne Aymon Paire-Ficout, Dominique S Blanc, Bruno Grandbastien, Laurence Senn

Background: The hospital wastewater system has been reported as a source of nosocomial acquisition of carbapenemase producing Enterobacteriaceae (CPE) in various settings. Cleaning and disinfection protocols or replacement of contaminated equipment often fail to eradicate these environmental reservoirs, which can lead to long-term transmission of CPE. We report a successful multimodal approach to control a New Delhi metallo-beta-lactamase positive Klebsiella pneumoniae (NDM-KP) nosocomial outbreak implicating contamination of sink traps in a low-incidence setting.

Methods: Following the incidental identification of NDM-KP in a urine culture of an inpatient, we performed an epidemiological investigation, including patient and environmental CPE screening, and whole genome sequencing (WGS) of strains. We also implemented multimodal infection prevention and control (IPC) measures, namely the isolation of cases, waterless patient care, replacement of contaminated P-traps and connecting pieces, and bleach and steam disinfection of sinks for 6 months, followed by patient and environmental screenings for eradication.

Results: Between February and May 2022, five NDM-KP cases were identified in an eight-bed neurosurgical intermediate care unit. Among the eight sink traps of the unit, three were positive for NDM-KP. Patient and environmental isolates belonged to multilocus sequence typing ST-268. All isolate genomes were genetically very similar suggesting cross-transmission and a potential role of the environment as the source of transmissions. Following the introduction of combined IPC measures, no new case was subsequently detected and sink traps remained negative for NDM-KP within 6 months after the intervention.

Conclusion: The implementation of multimodal IPC measures, including waterless patient care combined with the replacement and disinfection of P-traps and connecting pieces, was successful in the control of NDM-KP after eight months. In a low-incidence setting, this approach has made it possible to pursue the objective of zero transmission of carbapenemase-producing Enterobacteriaceae (CPE).

背景:据报道,在各种环境中,医院废水系统是产碳青霉烯酶肠杆菌科细菌 (CPE) 的院内感染源。清洁和消毒方案或更换受污染的设备往往无法根除这些环境蓄水池,从而导致 CPE 的长期传播。我们报告了一种成功控制新德里金属-β-内酰胺酶阳性肺炎克雷伯菌(NDM-KP)院内爆发的多模式方法,该方法牵涉到低发病率环境中的水槽收集器污染:在一名住院病人的尿液培养中偶然发现 NDM-KP 后,我们进行了流行病学调查,包括病人和环境 CPE 筛查以及菌株的全基因组测序 (WGS)。我们还实施了多模式感染预防和控制(IPC)措施,即隔离病例、无水病人护理、更换受污染的 P 型捕捉器和连接件、对水槽进行为期 6 个月的漂白剂和蒸汽消毒,然后对病人和环境进行筛查,以根除感染:结果:2022 年 2 月至 5 月间,一个拥有 8 张病床的神经外科中级护理病房发现了 5 例 NDM-KP 病例。在该病房的 8 个水槽中,有 3 个对 NDM-KP 呈阳性反应。患者和环境分离物属于多焦点序列分型 ST-268。所有分离株的基因组在遗传学上非常相似,表明存在交叉传播,环境可能是传播源。在采取综合 IPC 措施后,没有发现新的病例,而且在干预措施后的 6 个月内,水槽捕集器对 NDM-KP 的检测仍为阴性:结论:实施多模式 IPC 措施,包括无水病人护理、更换和消毒 P 型水槽和连接件,在 8 个月后成功控制了 NDM-KP。在发病率较低的环境中,这种方法实现了产碳青霉烯酶肠杆菌科细菌(CPE)零传播的目标。
{"title":"Successful control of an environmental reservoir of NDM-producing Klebsiella pneumoniae associated with nosocomial transmissions in a low-incidence setting.","authors":"Estelle Moulin, Paraskevas Filippidis, Corinne Aymon Paire-Ficout, Dominique S Blanc, Bruno Grandbastien, Laurence Senn","doi":"10.1186/s13756-024-01488-0","DOIUrl":"10.1186/s13756-024-01488-0","url":null,"abstract":"<p><strong>Background: </strong>The hospital wastewater system has been reported as a source of nosocomial acquisition of carbapenemase producing Enterobacteriaceae (CPE) in various settings. Cleaning and disinfection protocols or replacement of contaminated equipment often fail to eradicate these environmental reservoirs, which can lead to long-term transmission of CPE. We report a successful multimodal approach to control a New Delhi metallo-beta-lactamase positive Klebsiella pneumoniae (NDM-KP) nosocomial outbreak implicating contamination of sink traps in a low-incidence setting.</p><p><strong>Methods: </strong>Following the incidental identification of NDM-KP in a urine culture of an inpatient, we performed an epidemiological investigation, including patient and environmental CPE screening, and whole genome sequencing (WGS) of strains. We also implemented multimodal infection prevention and control (IPC) measures, namely the isolation of cases, waterless patient care, replacement of contaminated P-traps and connecting pieces, and bleach and steam disinfection of sinks for 6 months, followed by patient and environmental screenings for eradication.</p><p><strong>Results: </strong>Between February and May 2022, five NDM-KP cases were identified in an eight-bed neurosurgical intermediate care unit. Among the eight sink traps of the unit, three were positive for NDM-KP. Patient and environmental isolates belonged to multilocus sequence typing ST-268. All isolate genomes were genetically very similar suggesting cross-transmission and a potential role of the environment as the source of transmissions. Following the introduction of combined IPC measures, no new case was subsequently detected and sink traps remained negative for NDM-KP within 6 months after the intervention.</p><p><strong>Conclusion: </strong>The implementation of multimodal IPC measures, including waterless patient care combined with the replacement and disinfection of P-traps and connecting pieces, was successful in the control of NDM-KP after eight months. In a low-incidence setting, this approach has made it possible to pursue the objective of zero transmission of carbapenemase-producing Enterobacteriaceae (CPE).</p>","PeriodicalId":7950,"journal":{"name":"Antimicrobial Resistance and Infection Control","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11520856/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142520776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A multicenter study comparing the bacterial reduction on flexible endoscopes without a working channel between UV-C light disinfection versus standard endoscope Washer Disinfection: a randomized controlled trial. 一项多中心研究,比较紫外线-C 光消毒与标准内窥镜清洗消毒对无工作通道的柔性内窥镜的细菌减少效果:随机对照试验。
IF 4.8 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-26 DOI: 10.1186/s13756-024-01486-2
Yana Halmans, D J Wellenstein, M Romijn, A J M van Bemmel, H van den Berge, R A Scheeren, J S Kalpoe, R Klont, J H van Zeijl, H Sikkema, S M Euser, J Hopman, R P Takes, G B van den Broek

Background: To prevent cross-contamination between patients, adequate reprocessing is necessary when using flexible endoscopes (FEs) without a working channel. The current reprocessing process using an Endoscope Washer Disinfector (EWD) is time-consuming. Ultraviolet light group C (UV-C) exposition is an alternative and fast disinfection method and has previously been shown to adequately reduce Colony Forming Units (CFUs) on FEs without a working channel. The objective of this study was to examine whether UV-C light is as effective in reducing CFUs on contaminated FEs without a working channel compared to the EWD.

Methods: FEs without a working channel were collected in three different Otorhinolaryngology Departments in the Netherlands. After pharyngolaryngoscopy, a manual pre-cleaning with tap water was performed and a culture was collected by rolling the distal 8-10 cm of the FE over an agar plate. Next, the FE was randomly assigned to be disinfected with UV-C light (D60) or the EWD (gold standard). After disinfection, another culture was taken. The primary outcome was microbiological contamination, defined by Colony Forming Units (CFU).

Results: 600 FEs without a working channel were randomized. After clinical use and manual pre-cleaning, 239/300 (79.7%) FEs in the UV-C group and 262/300 (87.3%) FEs in the EWD group were contaminated (i.e., > 0 CFU). FEs without culture confirmed contamination were excluded from further analysis. After UV-C light disinfection, 195/239 (81.6%) FEs showed 0 CFUs, compared to 187/262 (71.4%) FEs disinfected with the EWD (p < 0.01). A multivariate logistics regression analysis showed an increased odds of 0 CFUs when using UV-C light (OR 1.83, 95% CI 1.19-2.79; p < 0.01), conditional on participating hospitals and types of FE.

Conclusions: UV-C light disinfection of FEs without a working channel appears more effective in reducing CFUs compared to the EWD and might be a good alternative disinfection method.

Trial registration: Not applicable.

背景:为了防止病人之间的交叉感染,在使用没有工作通道的柔性内窥镜(FE)时,必须进行充分的再处理。目前使用内窥镜清洗消毒器(EWD)进行的再处理过程非常耗时。C 组紫外线(UV-C)照射是一种替代性的快速消毒方法,以前的研究表明它能充分减少无工作通道 FE 上的菌落形成单位(CFU)。本研究的目的是检验与 EWD 相比,紫外线-C 是否能有效减少无工作通道的受污染纤维素上的菌落形成单位:方法: 在荷兰三个不同的耳鼻喉科收集无工作通道的 FE。咽喉内窥镜检查后,用自来水进行人工预清洁,并在琼脂平板上滚动 FE 的远端 8-10 厘米收集培养物。然后,随机分配 FE 用紫外线-C 光(D60)或 EWD(金标准)消毒。消毒后,再进行一次培养。主要结果是微生物污染,以菌落形成单位(CFU)定义:随机抽取了 600 台无工作通道的 FE。经过临床使用和人工预清洁后,紫外线-C 组和 EWD 组分别有 239/300 台(79.7%)和 262/300 台(87.3%)FE 受污染(即 > 0 CFU)。没有经过培养确认污染的 FEs 被排除在进一步分析之外。紫外线-C 光消毒后,195/239(81.6%)个 FE 显示为 0 CFU,而使用 EWD 消毒的 187/262(71.4%)个 FE 显示为 0 CFU(p 结论:紫外线-C 光消毒后,FE 的 CFU 为 0,而使用 EWD 消毒的 187/262(71.4%)个 FE 显示为 0:紫外线-C 光消毒无工作通道的 FE 比 EWD 更能有效减少 CFU,可能是一种很好的替代消毒方法:试验注册:不适用。
{"title":"A multicenter study comparing the bacterial reduction on flexible endoscopes without a working channel between UV-C light disinfection versus standard endoscope Washer Disinfection: a randomized controlled trial.","authors":"Yana Halmans, D J Wellenstein, M Romijn, A J M van Bemmel, H van den Berge, R A Scheeren, J S Kalpoe, R Klont, J H van Zeijl, H Sikkema, S M Euser, J Hopman, R P Takes, G B van den Broek","doi":"10.1186/s13756-024-01486-2","DOIUrl":"10.1186/s13756-024-01486-2","url":null,"abstract":"<p><strong>Background: </strong>To prevent cross-contamination between patients, adequate reprocessing is necessary when using flexible endoscopes (FEs) without a working channel. The current reprocessing process using an Endoscope Washer Disinfector (EWD) is time-consuming. Ultraviolet light group C (UV-C) exposition is an alternative and fast disinfection method and has previously been shown to adequately reduce Colony Forming Units (CFUs) on FEs without a working channel. The objective of this study was to examine whether UV-C light is as effective in reducing CFUs on contaminated FEs without a working channel compared to the EWD.</p><p><strong>Methods: </strong>FEs without a working channel were collected in three different Otorhinolaryngology Departments in the Netherlands. After pharyngolaryngoscopy, a manual pre-cleaning with tap water was performed and a culture was collected by rolling the distal 8-10 cm of the FE over an agar plate. Next, the FE was randomly assigned to be disinfected with UV-C light (D60) or the EWD (gold standard). After disinfection, another culture was taken. The primary outcome was microbiological contamination, defined by Colony Forming Units (CFU).</p><p><strong>Results: </strong>600 FEs without a working channel were randomized. After clinical use and manual pre-cleaning, 239/300 (79.7%) FEs in the UV-C group and 262/300 (87.3%) FEs in the EWD group were contaminated (i.e., > 0 CFU). FEs without culture confirmed contamination were excluded from further analysis. After UV-C light disinfection, 195/239 (81.6%) FEs showed 0 CFUs, compared to 187/262 (71.4%) FEs disinfected with the EWD (p < 0.01). A multivariate logistics regression analysis showed an increased odds of 0 CFUs when using UV-C light (OR 1.83, 95% CI 1.19-2.79; p < 0.01), conditional on participating hospitals and types of FE.</p><p><strong>Conclusions: </strong>UV-C light disinfection of FEs without a working channel appears more effective in reducing CFUs compared to the EWD and might be a good alternative disinfection method.</p><p><strong>Trial registration: </strong>Not applicable.</p>","PeriodicalId":7950,"journal":{"name":"Antimicrobial Resistance and Infection Control","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11515285/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142493177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outbreak with OXA-23-producing Acinetobacter baumannii in a COVID-19 ICU cohort: unraveling routes of transmission. COVID-19重症监护室队列中产OXA-23鲍曼不动杆菌的爆发:揭示传播途径。
IF 4.8 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-19 DOI: 10.1186/s13756-024-01485-3
Sandra Zingg, Sabine Kuster, Matthias von Rotz, Aurore Portmann, Adrian Egli, Helena M B Seth-Smith, Pascal Schlaepfer, Daniel Goldenberger, Stefano Bassetti, Stephan Marsch, Hans Pargger, Richard Kuehl, Sarah Tschudin-Sutter

An outbreak of OXA-23-producing carbapenem-resistant Acinetobacter baumannii amongst ICU-patients with COVID-19 likely occurred by transmission through inanimate surfaces, potentially facilitated by a contaminated positioning pillow shared between patients. Subsequent rapid spread may have been caused by exposure to respiratory secretions contaminating healthcare worker's gloves and gowns during prone positioning.

在患有 COVID-19 的重症监护病房患者中爆发的产 OXA-23 耐碳青霉烯类鲍曼不动杆菌很可能是通过无生命表面传播的,而患者之间共用的被污染的体位枕则可能促成了这一传播。随后的快速传播可能是由于医护人员在俯卧位时接触了污染手套和手术服的呼吸道分泌物。
{"title":"Outbreak with OXA-23-producing Acinetobacter baumannii in a COVID-19 ICU cohort: unraveling routes of transmission.","authors":"Sandra Zingg, Sabine Kuster, Matthias von Rotz, Aurore Portmann, Adrian Egli, Helena M B Seth-Smith, Pascal Schlaepfer, Daniel Goldenberger, Stefano Bassetti, Stephan Marsch, Hans Pargger, Richard Kuehl, Sarah Tschudin-Sutter","doi":"10.1186/s13756-024-01485-3","DOIUrl":"10.1186/s13756-024-01485-3","url":null,"abstract":"<p><p>An outbreak of OXA-23-producing carbapenem-resistant Acinetobacter baumannii amongst ICU-patients with COVID-19 likely occurred by transmission through inanimate surfaces, potentially facilitated by a contaminated positioning pillow shared between patients. Subsequent rapid spread may have been caused by exposure to respiratory secretions contaminating healthcare worker's gloves and gowns during prone positioning.</p>","PeriodicalId":7950,"journal":{"name":"Antimicrobial Resistance and Infection Control","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11491009/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142456355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clean Hospitals Day 2024: the technical domains of healthcare environmental hygiene. 2024 年清洁医院日:医疗环境卫生的技术领域。
IF 4.8 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-15 DOI: 10.1186/s13756-024-01479-1
Alexandra Peters, Pierre Parneix, Didier Pittet
{"title":"Clean Hospitals Day 2024: the technical domains of healthcare environmental hygiene.","authors":"Alexandra Peters, Pierre Parneix, Didier Pittet","doi":"10.1186/s13756-024-01479-1","DOIUrl":"https://doi.org/10.1186/s13756-024-01479-1","url":null,"abstract":"","PeriodicalId":7950,"journal":{"name":"Antimicrobial Resistance and Infection Control","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11475947/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142456353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of early and interim culture un-conversion in multidrug-resistant/rifampicin-resistant tuberculosis: a retrospective multi-center cohort study in China. 耐多药/耐利福平结核病早期和中期培养未转阴的预测因素:中国多中心队列回顾性研究。
IF 4.8 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-15 DOI: 10.1186/s13756-024-01480-8
Qing Chen, Wei He, Juan Du, Wanli Kang, Liping Zou, Xianzhen Tang, Peijun Tang, Chunhui Guo, Qing Pan, Qingdong Zhu, Song Yang, Zhouli Guo, Guihui Wu, Shenjie Tang

Background: We aimed to evaluate the predictors for early and interim culture conversion within 2 months and 6 months of treatment in multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) patients in China.

Methods: This study included adult MDR/RR-TB patients with a positive baseline sputum culture from 8 institutions located in different cities in China from May 2018 to January 2022. We mainly used logistic regression model to derive possible predictors of early and interim culture conversion.

Results: A total of 813 patients were enrolled and 28.5% of them received multidrug-resistant treatment regimens containing bedaquiline. Of these, 362 (44.5%) patients experienced culture conversion within 2 months of treatment, and 649 (79.8%) within 6 months. The results of the multivariable logistic regression analysis revealed that acid-fast bacilli smear positive (adjusted odds ratio [aOR] = 1.637, 95% confidence interval [CI] = 1.197-2.238), cavities (aOR = 1.539, 95% CI = 1.132-2.092), bilateral disease (aOR = 1.638, 95% CI = 1.183-2.269), and viral hepatitis (aOR = 2.585, 95% CI = 1.189-5.622) were identified as risk factors for early culture un-conversion within 2 months of treatment. Additionally, smoking history (aOR = 2.197, 95% CI = 1.475-3.273), previous treatment for tuberculosis (aOR = 1.909, 95% CI = 1.282-2.844), bilateral disease (aOR = 2.201, 95% CI = 1.369-3.537), viral hepatitis (aOR = 2.329, 95% CI = 1.094-4.962) were identified as risk factors for interim culture un-conversion within 6 months of treatment, while patients with regimen containing bedaquiline (aOR = 0.310, 95% CI = 0.191-0.502) was a protective factor.

Conclusions: A history of smoking, a baseline sputum AFB smear positive, lung cavities, bilateral disease, previous anti-tuberculosis treatment, or a comorbidity of viral hepatitis can be used as the predictors for early and interim culture un-conversion in MDR/RR-TB patients, while bedaquiline was a protective factor .

背景:我们旨在评估中国耐多药/耐利福平肺结核(MDR/RR-TB)患者在治疗2个月和6个月内早期和中期痰培养转阴的预测因素:本研究纳入了2018年5月至2022年1月期间来自中国不同城市8家机构的基线痰培养阳性的成年MDR/RR-TB患者。我们主要采用逻辑回归模型得出早期和中期培养转阴的可能预测因素:共有813名患者入组,其中28.5%的患者接受了含有贝达喹啉的耐多药治疗方案。其中,362 例(44.5%)患者在治疗 2 个月内经历了培养转换,649 例(79.8%)患者在 6 个月内经历了培养转换。多变量逻辑回归分析结果显示,酸性革兰氏染色阳性(调整赔率 [aOR] = 1.637,95% 置信区间 [CI] = 1.197-2.238)、龋齿(aOR = 1.539,95% CI = 1.132-2.092)、双侧疾病(aOR = 1.638,95% CI = 1.183-2.269)和病毒性肝炎(aOR = 2.585,95% CI = 1.189-5.622)被确定为治疗后 2 个月内早期培养未转阴的危险因素。此外,吸烟史(aOR = 2.197,95% CI = 1.475-3.273)、曾接受结核病治疗(aOR = 1.909,95% CI = 1.282-2.844)、双侧疾病(aOR = 2.201,95% CI = 1.369-3.537)、病毒性肝炎(aOR = 2.329,95% CI = 1.094-4.962)被认为是治疗后 6 个月内中期培养未转阴的风险因素,而使用含有贝达喹啉的治疗方案的患者(aOR = 0.310,95% CI = 0.191-0.502)是一个保护因素:吸烟史、基线痰 AFB 涂片阳性、肺空洞、双侧疾病、既往接受过抗结核治疗或合并病毒性肝炎可作为 MDR/RR-TB 患者早期和中期培养未转阴的预测因素,而贝达喹啉是一个保护因素。
{"title":"Predictors of early and interim culture un-conversion in multidrug-resistant/rifampicin-resistant tuberculosis: a retrospective multi-center cohort study in China.","authors":"Qing Chen, Wei He, Juan Du, Wanli Kang, Liping Zou, Xianzhen Tang, Peijun Tang, Chunhui Guo, Qing Pan, Qingdong Zhu, Song Yang, Zhouli Guo, Guihui Wu, Shenjie Tang","doi":"10.1186/s13756-024-01480-8","DOIUrl":"https://doi.org/10.1186/s13756-024-01480-8","url":null,"abstract":"<p><strong>Background: </strong>We aimed to evaluate the predictors for early and interim culture conversion within 2 months and 6 months of treatment in multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) patients in China.</p><p><strong>Methods: </strong>This study included adult MDR/RR-TB patients with a positive baseline sputum culture from 8 institutions located in different cities in China from May 2018 to January 2022. We mainly used logistic regression model to derive possible predictors of early and interim culture conversion.</p><p><strong>Results: </strong>A total of 813 patients were enrolled and 28.5% of them received multidrug-resistant treatment regimens containing bedaquiline. Of these, 362 (44.5%) patients experienced culture conversion within 2 months of treatment, and 649 (79.8%) within 6 months. The results of the multivariable logistic regression analysis revealed that acid-fast bacilli smear positive (adjusted odds ratio [aOR] = 1.637, 95% confidence interval [CI] = 1.197-2.238), cavities (aOR = 1.539, 95% CI = 1.132-2.092), bilateral disease (aOR = 1.638, 95% CI = 1.183-2.269), and viral hepatitis (aOR = 2.585, 95% CI = 1.189-5.622) were identified as risk factors for early culture un-conversion within 2 months of treatment. Additionally, smoking history (aOR = 2.197, 95% CI = 1.475-3.273), previous treatment for tuberculosis (aOR = 1.909, 95% CI = 1.282-2.844), bilateral disease (aOR = 2.201, 95% CI = 1.369-3.537), viral hepatitis (aOR = 2.329, 95% CI = 1.094-4.962) were identified as risk factors for interim culture un-conversion within 6 months of treatment, while patients with regimen containing bedaquiline (aOR = 0.310, 95% CI = 0.191-0.502) was a protective factor.</p><p><strong>Conclusions: </strong>A history of smoking, a baseline sputum AFB smear positive, lung cavities, bilateral disease, previous anti-tuberculosis treatment, or a comorbidity of viral hepatitis can be used as the predictors for early and interim culture un-conversion in MDR/RR-TB patients, while bedaquiline was a protective factor .</p>","PeriodicalId":7950,"journal":{"name":"Antimicrobial Resistance and Infection Control","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11481364/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142456356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug-resistance characteristics, genetic diversity, and transmission dynamics of multidrug-resistant or rifampicin-resistant Mycobacterium tuberculosis from 2019 to 2021 in Sichuan, China. 2019年至2021年中国四川耐多药或耐利福平结核分枝杆菌的耐药性特征、遗传多样性和传播动态。
IF 4.8 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-14 DOI: 10.1186/s13756-024-01482-6
Wenfeng Gao, Weina Wang, Jing Li, Yuan Gao, Shu Zhang, Hui Lei, Lu He, Ting Li, Jinge He

Background: Multidrug- or rifampicin-resistant tuberculosis (TB; MDR/RR-TB) is a significant public health threat. However, the mechanisms involved in its transmission in Sichuan, China are unclear. To provide a scientific basis for MDR/RR-TB control and prevention, we investigated the drug-resistance characteristics, genetic diversity, and transmission dynamics and analyzed the demographic and clinical characteristics of patients to identify risk factors for the acquisition of MDR/RR-TB in Sichuan, Western China.

Methods: Whole-genome sequencing was performed using a sample comprised of all MDR/RR-TB strains isolated from patients with pulmonary TB (≥ 15 years) at the 22 surveillance sites in Sichuan province between January 2019 and December 2021, to analyze genotypic drug resistance and genetic diversity. Moreover, we performed statistical analyses of the epidemiological characteristics and risk factors associated with the transmission dynamics of MDR/RR-TB.

Results: The final analysis included 278 MDR/RR TB strains. Lineage 2.2, the major sub-lineage, accounted for 82.01% (228/278) of isolates, followed by lineage 4.5 (9.72%, 27/278), lineage 4.4 (6.83%, 19/278), and lineage 4.2 (1.44%, 4/278). The drug resistance rates, ranging from high to low, were as follows: isoniazid (229 [82.37%]), streptomycin (177 [63.67%]), ethambutol (144 [51.80%]), pyrazinamide (PZA, 119 [42.81%]), fluoroquinolones (FQs, 93 [33.45%]). Further, the clofazimine, bedaquiline, and delamanid resistance rates were 2.88, 2.88, and 1.04%, respectively. The gene composition cluster rate was 32.37% (90/278). In addition, 83.81% (233/278) of MDR/RR-TB cases were determined to be likely caused by transmission. Finally, patients infected with lineage two strains and strains with the KatG S315T amino acid substitution presented a higher risk of MDR/RR-TB transmission.

Conclusion: Transmission plays a significant role in the MDR/RR-TB burden in Sichuan province, and lineage 2 strains and strains harboring KatG S315T have a high probability of transmission. Further, high levels of FQ and PZA drug resistance suggest an urgent need for drug susceptibility testing prior to designing therapeutic regimens. New anti-TB drugs need to be used standardly and TB strains should be regularly monitored for resistance to these drugs.

背景:耐多药或耐利福平结核病(TB;MDR/RR-TB)是一个严重的公共卫生威胁。然而,其在中国四川的传播机制尚不清楚。为了给 MDR/RR-TB 的控制和预防提供科学依据,我们调查了耐药性特征、遗传多样性和传播动态,并分析了患者的人口和临床特征,以确定中国西部四川地区获得 MDR/RR-TB 的风险因素:在2019年1月至2021年12月期间,对四川省22个监测点从肺结核患者(≥15岁)中分离的所有MDR/RR-TB菌株进行全基因组测序,分析基因型耐药性和遗传多样性。此外,我们还对与MDR/RR-TB传播动态相关的流行病学特征和风险因素进行了统计分析:最终分析包括 278 株 MDR/RR 结核菌株。2.2系是主要的亚系,占分离株的82.01%(228株/278株),其次是4.5系(9.72%,27株/278株)、4.4系(6.83%,19株/278株)和4.2系(1.44%,4株/278株)。耐药率从高到低依次为:异烟肼(229 [82.37%])、链霉素(177 [63.67%])、乙胺丁醇(144 [51.80%])、吡嗪酰胺(PZA,119 [42.81%])、氟喹诺酮类(FQs,93 [33.45%])。此外,氯法齐明、贝达喹啉和delamanid的耐药率分别为2.88%、2.88%和1.04%。基因组成群集率为 32.37%(90/278)。此外,83.81%(233/278)的 MDR/RR-TB 病例被确定可能是由传播引起的。最后,感染二系菌株和 KatG S315T 氨基酸置换菌株的患者发生 MDR/RR-TB 传播的风险较高:结论:传播在四川省 MDR/RR-TB 负担中起着重要作用,2 系菌株和携带 KatG S315T 的菌株具有较高的传播可能性。此外,高水平的 FQ 和 PZA 耐药性表明,在设计治疗方案之前,迫切需要进行药敏试验。需要规范使用新的抗结核药物,并定期监测结核菌株对这些药物的耐药性。
{"title":"Drug-resistance characteristics, genetic diversity, and transmission dynamics of multidrug-resistant or rifampicin-resistant Mycobacterium tuberculosis from 2019 to 2021 in Sichuan, China.","authors":"Wenfeng Gao, Weina Wang, Jing Li, Yuan Gao, Shu Zhang, Hui Lei, Lu He, Ting Li, Jinge He","doi":"10.1186/s13756-024-01482-6","DOIUrl":"https://doi.org/10.1186/s13756-024-01482-6","url":null,"abstract":"<p><strong>Background: </strong>Multidrug- or rifampicin-resistant tuberculosis (TB; MDR/RR-TB) is a significant public health threat. However, the mechanisms involved in its transmission in Sichuan, China are unclear. To provide a scientific basis for MDR/RR-TB control and prevention, we investigated the drug-resistance characteristics, genetic diversity, and transmission dynamics and analyzed the demographic and clinical characteristics of patients to identify risk factors for the acquisition of MDR/RR-TB in Sichuan, Western China.</p><p><strong>Methods: </strong>Whole-genome sequencing was performed using a sample comprised of all MDR/RR-TB strains isolated from patients with pulmonary TB (≥ 15 years) at the 22 surveillance sites in Sichuan province between January 2019 and December 2021, to analyze genotypic drug resistance and genetic diversity. Moreover, we performed statistical analyses of the epidemiological characteristics and risk factors associated with the transmission dynamics of MDR/RR-TB.</p><p><strong>Results: </strong>The final analysis included 278 MDR/RR TB strains. Lineage 2.2, the major sub-lineage, accounted for 82.01% (228/278) of isolates, followed by lineage 4.5 (9.72%, 27/278), lineage 4.4 (6.83%, 19/278), and lineage 4.2 (1.44%, 4/278). The drug resistance rates, ranging from high to low, were as follows: isoniazid (229 [82.37%]), streptomycin (177 [63.67%]), ethambutol (144 [51.80%]), pyrazinamide (PZA, 119 [42.81%]), fluoroquinolones (FQs, 93 [33.45%]). Further, the clofazimine, bedaquiline, and delamanid resistance rates were 2.88, 2.88, and 1.04%, respectively. The gene composition cluster rate was 32.37% (90/278). In addition, 83.81% (233/278) of MDR/RR-TB cases were determined to be likely caused by transmission. Finally, patients infected with lineage two strains and strains with the KatG S315T amino acid substitution presented a higher risk of MDR/RR-TB transmission.</p><p><strong>Conclusion: </strong>Transmission plays a significant role in the MDR/RR-TB burden in Sichuan province, and lineage 2 strains and strains harboring KatG S315T have a high probability of transmission. Further, high levels of FQ and PZA drug resistance suggest an urgent need for drug susceptibility testing prior to designing therapeutic regimens. New anti-TB drugs need to be used standardly and TB strains should be regularly monitored for resistance to these drugs.</p>","PeriodicalId":7950,"journal":{"name":"Antimicrobial Resistance and Infection Control","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11472436/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142456354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Antimicrobial Resistance and Infection Control
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1